B

BioCryst Pharmaceuticals

Develops oral drugs for rare diseases

Vice President Global Clinical Development

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeNorth Carolina, USANo salary listedRemote

About the Job

Requirements

  • MD with a minimum of 10 years of pharmaceutical development experience, preferably gained in a sponsor and/or contract research organization role, and at least 5 years in a senior management role, or an equivalent combination of education and experience.
  • Demonstrated drug development experience and a record of driving results within the biotechnology or pharmaceutical industry, including expertise in clinical trial design, conduct, analysis, and interpretation of scientific data.
  • Experience building, training, mentoring, and motivating clinical development teams in industry, ideally for an emerging biopharmaceutical company pursuing novel therapeutics.
  • Highly developed line management and matrix team skills, including collaboration and influencing across functions at senior level.
  • Ability to manage a broad range of activities and priorities, progress programs and timelines rapidly, and drive accomplishments.

Responsibilities

  • Be accountable for performance against key trial metrics, organizational objectives, and development and implementation of operational strategy across the scientific disciplines supporting Clinical Development.
  • Lead, shape, oversee, or direct changes required in Clinical Development functions to scale and deliver high-quality clinical trials across multiple assets and indications.
  • Set goals and evaluate performance for direct reports and the broader department; ensure staff understand their career paths and support training and leadership development plans.
  • Manage departmental budgets and resourcing strategy to support the needs of all clinical programs and phases.
  • Build a quality-focused clinical infrastructure, identify areas for improvement, and propose and implement corrective actions in consultation with senior management.
  • Develop standard operating procedures to ensure operational processes, systems, and standards are consistent with regulatory requirements and implemented and documented consistently across trials.
  • Ensure inspection readiness of active and completed studies.
  • Set the outsourcing strategy for clinical development in conjunction with appropriate interdepartmental team members and ensure a robust vendor oversight program.
  • Serve as the point of contact for escalation management of external vendors and contract research organizations.
  • Collaborate with stakeholders to strengthen clinical trial design, increase scientific rigor and likelihood of success, leverage appropriate regulatory pathways, and advance pipeline compounds efficiently.
  • Participate in relevant governance bodies and processes, including the Portfolio Review Committee, stage gate reviews, and Development Review Group, providing guidance to project teams.
  • Partner in developing a communication strategy that presents the value of the company’s programs and products to prospective key opinion leaders and investigators.
  • Champion a patient-focused mindset and approach that fosters collaboration and consistency across the department.
  • Ensure advocacy and the voice of the patient are represented in the planning, design, and conduct of clinical trials.

About the Company

BioCryst Pharmaceuticals

Develops oral drugs for rare diseases

BioCryst Pharmaceuticals develops oral small-molecule drugs aimed at treating rare diseases, with a focus on hereditary angioedema (HAE). The company uses traditional cell biology and medicinal chemistry to design synthetic compounds that target specific protein pathways involved in disease. Its products work as oral therapies that modulate disease-related proteins to reduce symptoms and improve daily functioning, progressing from discovery through clinical trials toward commercialization. BioCryst differentiates itself by concentrating on rare diseases and pursuing oral, non-biologic treatments, leveraging a combined science approach and a patient-focused strategy to bring therapies to market. Its goal is to deliver meaningful, clinically validated treatments that enable patients to engage more fully in everyday activities and improve their quality of life, supported by its drug pipeline and potential licensing opportunities.

Company size
501-1,000
Company stage
IPO
Headquarters
Durham, NC
Founded
1986

Recently Posted Jobs

Explore more opportunities at BioCryst Pharmaceuticals

See more jobs